Next Article in Journal
Pharmacogenomics Testing in Phase I Oncology Clinical Trials: Constructive Criticism Is Warranted
Next Article in Special Issue
Integrated Multi-Omics Maps of Lower-Grade Gliomas
Previous Article in Journal
DNA Repair Enzyme Poly(ADP-Ribose) Polymerase 1/2 (PARP1/2)-Targeted Nuclear Imaging and Radiotherapy
Previous Article in Special Issue
Toward More Comprehensive Homologous Recombination Deficiency Assays in Ovarian Cancer Part 2: Medical Perspectives
 
 
Review

Article Versions Notes

Cancers 2022, 14(5), 1132; https://doi.org/10.3390/cancers14051132
Action Date Notes Link
article xml file uploaded 23 February 2022 08:44 CET Original file -
article xml uploaded. 23 February 2022 08:44 CET Update -
article pdf uploaded. 23 February 2022 08:44 CET Version of Record -
article xml file uploaded 23 February 2022 08:45 CET Update -
article xml uploaded. 23 February 2022 08:45 CET Update -
article pdf uploaded. 23 February 2022 08:45 CET Updated version of record -
article html file updated 23 February 2022 08:45 CET Original file -
article html file updated 23 February 2022 08:46 CET Update -
article xml file uploaded 23 February 2022 11:00 CET Update -
article xml uploaded. 23 February 2022 11:00 CET Update https://www.mdpi.com/2072-6694/14/5/1132/xml
article pdf uploaded. 23 February 2022 11:00 CET Updated version of record https://www.mdpi.com/2072-6694/14/5/1132/pdf
article html file updated 23 February 2022 11:01 CET Update -
article html file updated 1 August 2022 02:11 CEST Update https://www.mdpi.com/2072-6694/14/5/1132/html
Back to TopTop